key: cord-0314852-1oaq1rn6
authors: Correa-Macedo, W.; Fava, V. M.; Orlova, M.; Cassart, P.; Olivenstein, R.; Sanz, J.; Dumaine, A.; Sindeaux, R. H.; Yotova, V.; Pacis, A.; Girouard, J.; Kalsdorf, B.; Lange, C.; Routy, J.-P.; Barreiro, L. B.; Schurr, E.
title: Epigenetic impairment and blunted transcriptional response to Mycobacterium tuberculosis of alveolar macrophages from persons living with HIV
date: 2021-01-29
journal: nan
DOI: 10.1101/2021.01.26.21250318
sha: 3dbbc7255851f55dbba25a1c82c9602cdf37cdf6
doc_id: 314852
cord_uid: 1oaq1rn6

Persons living with HIV (PLWH) are at increased risk of tuberculosis (TB). HIV-associated TB is often the result of recent infection with Mycobacterium tuberculosis (Mtb) followed by rapid progression to disease. Alveolar macrophages (AM) are the first cells of the innate immune system that engage Mtb, but how HIV and antiretroviral therapy (ART) impact on the anti-mycobacterial response of AM is not known. To investigate the impact of HIV and ART on the transcriptomic and epigenetic response of AM to Mtb, we obtained AM by bronchoalveolar lavage from 20 PLWH receiving ART, 16 control subjects who were HIV-free (HC), and 14 subjects who received ART as pre-exposure prophylaxis (PrEP) to prevent HIV infection. Following in-vitro challenge with Mtb, AM from each group displayed overlapping but distinct profiles of significantly up- and down-regulated genes in response to Mtb. Compared to HC subjects, AM isolated from PLWH and PrEP subjects presented a substantially weaker transcriptional response. Further investigation of chromatin structure revealed that AM from control subjects challenged with Mtb responded with pronounced accessibility changes in over ten thousand regions. In stark contrast, AM obtained from PLWH and PrEP subjects displayed no significant changes in their chromatin state in response to Mtb. Collectively, these results revealed a previously unknown adverse effect of ART on the epigenetic landscape and transcriptional responsiveness of AM.

Tuberculosis (TB) is globally the leading cause of death due to a single pathogen. In 2018, there were an estimated 1.45 million deaths caused by TB, which included 250,000 people living with the human immunodeficiency virus (HIV) (1). Of the estimated 10 million people who fell ill with TB, 850,000 were persons living with HIV (PLWH) indicating a 2.2-fold increased risk of death due to TB in HIV-positive relative to HIV-negative persons. Globally, the proportion of notified HIV-positive TB cases on antiretroviral therapy was 86% with large gaps among countries (1). However, even people on long-term antiretroviral therapy (ART) still have significantly increased risk of developing TB (2) , which is usually the result of new infection rather than reactivation of latent TB (3) (4) (5) (6) .

Transmission of Mycobacterium tuberculosis (Mtb) occurs by aerosols that are inhaled by an exposed person. Results from the mouse model show that after reaching the lung alveoli, Mtb bacilli are being rapidly taken up by alveolar macrophages (AM). Following a delay of approximately 10 days, successful establishment of infection occurs once Mtb-infected AM traverse the airway epithelium and establish themselves in the lung interstitium. There, transfer of Mtb to permissive inflammatory macrophages occurs and T-cell priming is initiated in the draining lymph nodes (7) . However, much of the AM-Mtb interaction in the alveoli remains unknown.

In humans, not each exposure results in successful infection, and a subset of highly exposed persons entirely resist infection as inferred from the absence of CD4 + T cell anti-Mtb immunity (8, 9) . Hence it seems possible that human AM are capable to limit transfer of inhaled Mtb bacilli to the lung interstitium. The increased risk of Mtb infection and TB disease for PLWH may . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint therefore reflect an impaired ability of AM to restrict Mtb to the alveoli, thus placing early events in the Mtb-host interaction as a central aspect of TB resistance.

Based on the above considerations, we decided to investigate the transcriptome and epigenome of the ex-vivo AM-Mtb interaction employing AM obtained from PLWH and HIV-negative participants. Since ART is given to most PLWH, we also included an additional control group consisting of persons who are HIV-negative receiving ART for pre-exposure prophylaxis (PrEP).

To investigate the influence of HIV on the ability of AM to mount a response to Mtb infection, we studied three groups of subjects: PLWH receiving ART (n=20), persons without HIV but receiving ART as pre-exposure prophylaxis (PrEP; n=14) and persons without HIV not receiving PrEP (healthy controls, HC; n=16, Table 1 ). We obtained AM by BAL from all subjects and challenged the cells in vitro with Mtb. RNA and DNA were isolated from uninfected and Mtb challenged cells and used to assess gene expression levels by RNA-seq, chromatin structure by ATAC-seq, and presence of the histone activation mark H3K27ac by ChIP-seq (Fig. 1A) .

However, due to different quality-control procedures and variable numbers of AM obtained per subject, different counts of subjects were used for the transcriptomics and epigenetics experiments (Fig. 1A) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint

Across the three phenotypic groups, we identified 1,626 differentially expressed genes (DEG) in response to Mtb (Data File S1). However, there were pronounced DEG count differences in their transcriptional responses (Fig. 1B) . AM from HC subjects showed 1,434 DEG in response to

Mtb as compared to only 679 and 255 DEG in PLWH and PrEP subjects, respectively ( Fig. 1B and Fig. S1A ). The magnitude of AM transcriptional response to Mtb also differed among the three groups. The smallest mean absolute log2 fold change (log2FC) in response to Mtb infection was observed among PrEP subjects while HC subjects displayed the strongest transcriptional response. (Fig. 1C and Fig. S1A ). To test if Mtb effects in PLWH and PrEP subjects were weaker for all DEGs or only for specific gene sets, we assessed the correlations of Mtb-triggered logFC across the three groups. We observed that log2FC values were strongly correlated among all three groups, but consistently higher for corresponding genes from HC subjects (Fig. S1B) which suggested a general transcriptional impairment in cells from PLWH and PrEP subjects.

Pathway and GO-term enrichment analysis revealed that Mtb-induced transcriptional changes were enriched in biological functions representative of macrophage anti-mycobacterial host responses, such as interferon (IFN) and Toll-like receptor signalling pathways (Fig. 1D) .

However, compared to HC subjects, the number of significant GO-terms/pathways was substantially lower for the PLWH and PrEP groups (Table S1 ). Moreover, even among shared significant terms, the cumulative transcriptional response of genes in these terms was stronger in the HC group, which further emphasized the blunted anti-mycobacterial response by PLWH and PrEP subjects (Fig. 1D) . We also tested which genes had a significantly different magnitude of response to Mtb among phenotype groups ( Fig. 1E and Data File S1). We identified 333 genes . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01. 26.21250318 doi: medRxiv preprint significantly different between the groups (Data File S2) with the majority displaying lower upregulation in response to Mtb for PLWH and PrEP groups relative to the HC group (Fig. S1, C   and D and Table S1 ). These results provided a formal confirmation that the transcriptional response to Mtb challenge by AM of HC was more vigorous compared to the one mounted by PrEP and PLWH subjects.

To explore if the group differences were mainly driven by strong outliers, we derived per subject average log2FC across DEG in significant pathways/GO-terms. We found that AM from HC subjects displayed a more pronounced group transcriptional response to Mtb. For example, the mean log2FC for the term "I-kappaB kinase/NF-kappaB signaling" was 3.22-fold (p = 2.4×10 −3 ) and 2.39-fold (p = 3.8×10 −2 ) higher in HC as compared to PLWH and PrEP, respectively (Fig.   1F ). GO-terms and pathways tagged by the DEG from PLWH and PrEP vs HC, which were significantly more induced in AM from HC subjects, revealed a predominance of innate-immune and intracellular defense response terms (Fig. 1G) . This observation alongside the exclusion of possible outlier-driven group differences supported the reduced ability of AM from PLWH and PrEP subjects to mount an effective anti-mycobacterial transcriptional response to challenge with Mtb.

Next, we evaluated Mtb-triggered epigenetic changes of AM chromatin accessibility and H3K27 acetylation. Analysis of Differentially Open Chromatin (DOC) in response to Mtb indicated that AM from HC had significant increased accessibility (opening) in 8,389 regions and repression (closing) in 3,971 regions ( Fig. 2A ; Data File S3). In contrast, AM isolated from PLWH or PrEP . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint subjects displayed near complete absence of significant chromatin remodeling in response to Mtb (Fig. 2, A and B) . A broad-based epigenetic impairment was confirmed for AM from PLWH subjects by tracking regions with differently H3K27 acetylation (DAc), a mark of active chromatin ( Fig. 3A ; Data File S4). Pathway and GO-term enrichment analyses of genes annotated to DOC and DAc in HC identified typical viral and bacterial response terms ( Fig. 2C;   Fig. 3B ). As in the transcriptomics analyses, the epigenetic response to Mtb by AM from HC strongly implicated host immune response to pathogens and immune-related signalling pathways, which was mainly driven by opening DOCs and regions with increased acetylated H3K27 ( Fig. 2D ; Table S2 ). Examples of genes with DOCs and DAc at the gene transcription start site (TSS) were CXCL10, IFI44L, APOBEC3A and MX1 ( Fig. S3 and S4 ).

The three groups differed with respect to several covariates ( Table 1) . Among the HC group, the proportion of females was higher, and the use of recreational drugs was lower compared to the PLWH and PrEP groups. Subjects in the PrEP group on average were younger compared to the two other groups. The duration of ART was longer for PLWH (mean = 12.12 years, standard deviation (SD) = 7.64) than PrEP subjects (mean = 3 years, SD = 1,47). All PrEP subjects received Emtricitabine and Tenofovir disoproxil fumarate (TDF) while among PLWH there was a wider spread of ART drug regimens. However, only 4 out of 20 subjects had not received TDF at the time of enrolment ( Table 1) . Most of the inter-subject variability was accounted for by the analytical approach employed. Still, given the strong heterogeneity of study subjects we investigated the impact of smoking, recreational drug use and age on Mtb-triggered chromatin . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint and transcriptional responses. We found that recreational drug use did not explain the reduced transcriptional activity or absence of chromatin changes in response to Mtb among PLWH and PrEP subjects ( Fig. 1F and Fig. 4A ). Age and duration of ART/PrEP were also unlikely confounders since PLWH and PrEP subjects differed significantly in age and ART duration, yet both groups showed similar reduced transcriptional activity and lack of chromatin changes relative to HC subjects following challenge with Mtb (Fig. 4, B and C) . Moreover, when stratifying HC and PLWH by age, HC subjects of 40 years and older showed pronounced Mtbtriggered chromatin changes that were not observed for PLWH subjects (Fig. 4D) . In addition to the covariates listed in Table 1 , we also considered possible group-dependent differences in phagocytic activity. Since the yields of AM were generally not sufficient to conduct independent assessment of phagocytic activity, we used presence of Mtb reads in ATAC-seq libraries as proxy and failed to detect any significant group-dependent differences (Fig. 4E) .

To link Mtb-triggered epigenetic changes in AM from HC subjects with increased gene expression, we evaluated the enrichment of transcription factors (TFs) motifs in Mtb-triggered DOC and DAc regions and found an enrichment of IFN-regulatory factor (IRF) motifs in those regions ( Table 2 ). Next, we compared the average difference in TF footprint depth between Mtb challenged and non-challenge AM to estimate TF activity. Of the 682 TFs obtained from the JASPAR catalog, 21 had significantly higher activity (increased footprint depth) in DOC regions after Mtb challenge (Fig. 5A) . Among these significant TFs were IRF9 (part of the antimycobacterial host response) and ZNF684 (a TB biomarker). Of note, Mtb challenge had triggered a higher fold change for IRF9 and ZNF684 RNA expression in AM from HC subjects . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint compared to AM from PrEP or PLWH subjects (Fig. 5B) . Moreover, IRF9 and ZNF684 footprints responsive to Mtb challenge were enriched in the transcription starting site (TSS) of genes that are part of the IFN signalling pathway (p = 8.9 x 10 -6 and p = 0.03, respectively) ( Fig.   5C ). Unexpectedly, we also observed an enrichment of IRF9 active footprints in the TSS of genes of the TNF signalling pathway (p = 0.01) (Fig. 5C) . ZNF684 active footprints were observed in the core promoter of TNF after Mtb challenge providing a direct link to a major proinflammatory cytokine (Fig. 5D) . Moreover, in support of a coordinated effect of these two TFs, an active footprint for ZNF684 was observed in the promoter region of IRF9 (Fig. 5D ).

To further assess the link between Mtb-dependent TF binding and RNA expression, we evaluated if the 135 expressed genes with active IRF9 footprint at the TSS were differentially expressed in HC following Mtb challenge. We observed that 65 out of the 135 genes were DEGs (57 upregulated and 8 down-regulated) following Mtb challenge (p = 7.9 x 10 -23 , Table S3 and Data File 5). AM from PLWH and PrEP had lower logFC in response to Mtb for all 65 DEGs (Data File 5). Of the 57 up-regulated DEGs with IRF9 TSS footprint, 17 were part of the IFN or TNF pathways, including NOD2 and ISG15 (Fig. 5D) . Collectively, these data showed that the epigenetic response observed in AM from HC subjects promoted the binding of key transcriptions factors required for IFN and TNF signalling. The locked state of chromatin in AM from PLWH and PrEP subjects was therefore likely to account, at least in part, for the reduced transcriptional activity of those cells in response to Mtb.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint

There is a scarcity of knowledge about the early fate of inhaled Mtb bacilli in the human lung.

Infection of human hosts with Mtb is inferred from detectable anti-Mtb immunity through either the in-vivo tuberculin skin test (TST) or ex-vivo IFN-γ release assays (IGRAs) (10) . However, these tests reflect T-cell immunity that is being generated in the lymph nodes, and not in the lung, several weeks after the initial uptake of Mtb (11) . Consequently, much of our knowledge about the Mtb-host interplay from inhalation to the development of acquired T cell immunity has been derived from observations in animal models. In the mouse, Mtb bacilli in the lung alveoli are taken up by AM (7). Infected AM function as niche for Mtb replication prior to the migration of Mtb-infected AM to the lung interstitium where Mtb are transferred to inflammatory macrophages that facilitate the induction of Mtb-specific T cell immunity (7) . The increased permissiveness of AM for Mtb in the mouse has been confirmed in a number of independent studies and appears to reflect the metabolic state of the cells (12, 13) .

It is not known how well this scenario is replicated in the human lung. One critical difference between the mouse model and humans is the ability of a subgroup of Mtb-exposed persons to avoid the development of classical T-cell immunity and TB disease even in the presence of long lasting Mtb exposure (9) . Recently, the phenotype of strong resistance to immune conversion of persons living in high Mtb exposure settings has been confirmed for HIV-infected but immunereconstituted people (14) . While the underlying mechanisms that preclude the development of classical T cell immunity are unknown, initial results implicate both non-classical T cells and B cells (14, 15) . How and where AM interact with these cells of the acquired immunity arm is not known. We also do not know how the strong persistent exposure of human AM to environmental . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. stimuli and pollutants impacts on AM physiology and anti-mycobacterial activity. An important influence of the environment on AM physiology is consistent with the pronounced interindividual differences observed in our study. Nevertheless, in our experiments all AM displayed an innate anti-mycobacterial immune response to Mtb that was dominated by IFN and TNF signalling suggesting that AM are directly involved in the host defense against Mtb. However, this anti-Mtb response was significantly weaker in AM from PLWH and PrEP subjects.

The impetus for our experiments was the well-known observation that PLWH are at increased risk to become infected with Mtb and to develop clinical TB disease (4) (5) (6) 16) . This increased susceptibility is still present in PLWH who have been immune-reconstituted with ART (2, 17) .

A detrimental effect of HIV on AM function has been shown in pre-ART patients including on their response to Mtb (18) . In our study we found no evidence for reduced phagocytic uptake of Mtb by AM across phenotypic groups. This is consistent with previous reports that AM obtained from PLWH showed no defect in phagocytosis of Salmonella Typhimurium compared to HIVnegative controls (19) . AM from PLWH on long term ART displayed a decreased ability to kill Streptococcus pneumoniae due to their HIV gp120-mediated reduced AM apoptotic activity (20, 21) . Consistent with this finding, reduced AM phagocytic activity of Staphylococcus aureus in a sample of PLWH/ART subjects was associated with detectable proviral DNA (22) . In our sample we found that 6 out of the 7 tested PLWH subjects had undetectable proviral counts arguing against a role of provirus in our sample (23) . Moreover, the differences in the transcriptional response to Mtb between the PrEP and PLWH groups were less pronounced as compared to the differences of both groups to HC participants which argues against HIV being the main cause of the blunted anti-Mtb response by AM.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint

The differences in the transcriptional response between the phenotype groups were graded and quantitative. However, the changes in Mtb-triggered chromatin structure of AM were sharply divided between PLWH and PrEP subjects compared to controls. Indeed, AM from both PLWH receiving ART and PrEP subjects displayed a near total lack of chromatin changes in response to

Mtb. This suggested an unknown effect on chromatin of the drugs used in the PrEP and ART

regimen. Yet, how drugs might impact the AM epigenetic responsiveness and the transcriptional response to Mtb is not clear. While the observed increased TF binding in DOC/DAc regions is consistent with the idea of the chromatin lock-down being the cause of the reduced transcriptional response, this causality remains to be more stringently established. Irrespective of the precise mechanisms, the blunted ability of AM to mount a response to an infectious insult may contribute to the known increased vulnerability to pulmonary disease of PLWH. For example, the prevalence of bacterial pneumonias and chronic obstructive pulmonary disease (COPD) are significantly increased in PLWH/ART patients (24, 25) . PLWH/ART patients also experience an increased risk of sepsis with poor outcome (26) . However, a more direct link of our findings can be made with TB for which PLWH on long term ART who have been immunereconstituted remain at increased risk (2, 17) . Since our data suggest that the blunted AM response to Mtb is predominantly mediated by the anti-viral drugs and not the virus, use of PrEP in settings of high TB transmission might require to consider the risk of TB versus protection from HIV. To our knowledge, no data are presently available that link PrEP with risk of TB. We note, however, that PrEP has been associated with reduced risk of SARS-CoV-2 virus infection in Spain (27, 28) . Efficient infection of epithelial cells by SARS-CoV-2 is dependent on the virus induced up-regulation of its ACE2 receptor (29) . If the impact of PrEP on chromatin . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint structure described here for AM also hold true for epithelial cells, this may underlie the protective effect observed. 

For downstream RNA and ATAC experiments AM were rinsed with warm PBS to remove damaged cells and debris before further processing. For RNA, cells were lysed with Trizol and kept at -80°C until extraction. For RNA isolation the miRNeasy kit (Qiagen, Germany) was used and RNA integrity (RIN) was assessed with the Agilent 2100 Bioanalyzer (Agilent Technologies, Waldbronn, Germany). Only samples with RIN >8 were selected for library preparation using TruSeq RNA Library Preparation Kit v2, Set A (Illumina, USA).

For chromatin accessibility using the ATACseq method (31, 32) ; AM were lifted with pre-warmed CellStripper solution (Corning, USA) and gentle pipetting. Viability was assessed with trypan . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint blue staining, and only samples with viability > 85% were used. We followed the protocol by Buenrostro et al. (32) . Briefly, 50,000 cells were used for generating challenged and nonchallenged libraries. AM were permeabilized with lysis buffer containing 0.05% IGEPAL. Nuclei were incubated with Tn5 transposase (Illumina, USA) and further ATAC-seq libraries were amplified for a total of 5-10 PCR cycles. Barcoded and multiplexed RNA or ATAC-seq libraries were sequenced on an Illumina HiSeq4000 sequencer at Genome Quebec, Montreal, Canada.

Samples from challenged and non-challenged AM were crosslinked with 1% w/v formaldehyde for 10 min at RT and immediately quenched for 5 min with 125 mM Glycine at RT. The formaldehyde fixed samples were then sonicated to 150-500 bp using a S220 (Covaris) and then ChIP-DNA prepared using a manual chromatin immunoprecipitation method with an Antibody-Antigen incubation of 18 hrs., followed by bead incubation for 135 minutes, and 6 x 5-minutes washing steps.

Approximately 0.5 million cells were used for each ChIP and ~50,000 cells for the input. We used H3K27ac antibody (Abcam, Ab4729, GR3211959-1). ChIP and Input libraries were prepared using the MicroPlex Library Preparation Kit (C05010012, Diagenode), with alterations including PCR enrichment (7 to 20 cycles) prior to size selection and use of Ampure beads for size selection (250-350 bp). Libraries for ChIPSeq were sequenced on an Illumina NovaSeq 6000 S2 SR100.

Detailed description for raw sequences processing to statistical analyses are provided in Supplementary Information. Briefly, Baseline and challenged transcriptome and epigenomic landscapes of AMs were determined following published protocols (31, 33) . Gene expression . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint readouts were generated using alignments and annotated set of transcripts as input to Salmon (34) . Differences in chromatin accessibility and H3K27ac levels were assessed with a countbased peak quantification as shown in (35) . Quantification files from each approach were merged as a single matrix, genes and peaks with low counts were filtered out and libraries were normalized, scaled and log2 transformed using edgeR and Limma-voom (36, 37) . We performed pathway and gene ontology enrichment analysis using three independent databases (KEGG, Reactome and AmiGO). Enrichment results were merged and the Benjamini-Hochberg FDR method was applied to raw p-values. We tested TF motif enrichment in DOCs and DAc regions using HOMER (39) . Mtb-triggered differences in TF footprint activity over DOC regions were estimated with HINT-ATAC (40) . TF motifs with FDR < 0.05 and activity score > 0.005 were considered significant.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint quantification matrices analysed is this work were submitted to NCBI's Gene Expression Omnibus repository (data is being processed, accession number will be available for publication). Fig. 1 Study design and results for differential gene expression by alveolar macrophages (AM) after challenge with Mycobacterium tuberculosis (Mtb).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (E) Bar graph summarizing genes that displayed significantly different log2FC between groups (differential Mtb response). The y-axis indicates the cumulative DEG count while the x-axis indicates the pair-wise group contrast. Dark colour shading represents genes with higher response (e.g. Mtb effect in PLWH vs HC subjects resulted in a positive log2FC difference)

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint while light shading depicts genes with lower response (negative log2FC difference). The union of all gene IDs identified across the three contrasts (n=401) results in 333 unique gene IDs. (F) Boxplot for three selected pathway/GO terms for genes with significant differential Mtb response between PLWH or PrEP against controls (n=302). For each term, the y-axis displays the mean log2FC and dots represent per-subject mean value for pooled DEG. Phenotypic groups are indicated below each box plot across the three terms. White dots represent mean log2FC for subjects who do not smoke cigarettes or used cannabis, while black dots depict smokers and/or cannabis users. To derive the subject mean log2FC, we used pooled DEG from the first two columns in panel E which were significant for interaction contrasts PLWH vs HC and PrEP vs HC, obtained subject-wise log2FC for each DEG and averaged the log2FC from all genes per subject. Results showed that group differences are not driven by outliers and that smoking, or cannabis consumption do not explain group differences. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. Dashed lines indicate the 5% FDR on the y-axis and the minimum log2FC of 0.2 on the x-axis.

In healthy controls (HC), 23.3% of the tested regions displayed significant chromatin . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. a, Volcano plots for H3K27 acetylation response to Mtb. Chromatin regions significantly acetylated at a false discovery rate (FDR) < 5% after Mtb challenge are marked in red and blue, respectively. The numbers of acetylated regions are given at the top. Significant changes in H3K27 acetylation, indicating active enhancers, were observed mostly for the healthy control (HC) group, which encompassed five subjects compared to 11 persons living with HIV on antiretroviral therapy (PLWH). While many peaks for H3K27ac did not pass FDR 5%, the magnitude of log2FC was higher in HC compared to PLWH.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint b, Enrichment analysis of genes assigned to regions with increased H3K27 acetylation for the HC response to Mtb. GO biological processes (BP), KEGG, and Reactome pathways with at least five assigned genes are plotted against the negative log10 FDR. A total of 167 out of 906 tested terms were significant. As observed for the chromatin changes, enrichment analysis indicated that in AM of HC subjects, Mtb challenge promoted higher acetylation in regions assigned to genes belonging to IFN and TNF signalling pathways as well as response to viral and bacterial pathogens.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2021. on the x-axis. (B) Boxplot for three selected pathway/GO terms for genes with significant differential Mtb response between PLWH or PrEP against HC (n=302). For each term, the y-axis displays the mean log2FC and dots represent per-subject mean value for pooled DEG from the three groups. White dots represent mean log2FC for subjects younger than 40 years at enrolment, while black dots depict subjects ≥ 40 years of age. To derive the subject mean log2FC, we used DEG from Fig. 1e which were part of significant pathway/GO terms, pooled the genes for each group, obtained the log2FC per subject for each DEG and averaged the log2FC from all genes per subject. (C) Boxplot showing the distribution of age at enrolment across the three studied groups. Subjects of the PLWH group were significantly older than the subjects of the healthy controls and PrEP groups. (D) Volcano plots for chromatin accessibility changes by AM in response to Mtb stratified by age for subjects of the HC and PLWH groups. Subjects tested were ≥ 40 years at enrolment. In this age class the HC, PLWH and PrEP groups encompassed 9, 15 and 3 subjects, respectively. Due to low subject count PrEP subjects were excluded from this stratified analysis. Significantly opened or closed chromatin regions at a false discovery rate (FDR) of 5% after Mtb challenge are represented by dots marked in red or blue, respectively.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint reads, after removing inter-individual variability, is plotted for each group i.e., healthy controls (HC), subjects on pre-exposure prophylaxis (PrEP), and persons living with HIV receiving . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250318 doi: medRxiv preprint antiretroviral treatments (PLWH) and condition (Mtb-challenged or not). (C) Percentage of genes in the TNF or IFN pathways that have IRF9 or ZNF684 footprints in their transcription starting site (TSS; ± 5kb from the promoter) was compared to all genes with TSS in DOC regions. As expected, we observed that IRF9 footprints are more frequent in genes assigned to Reactome's IFN signalling pathway compared to random TSS in DOCs. Surprisingly, IRF9 footprints were also more frequent than by chance in KEGG's TNF pathway. (D) ZNF684 and IRF9 footprints in selected IFN and TNF genes. The mean normalized fragment pileup is plotted on the y-axis as red and blue lines for non-infected and Mtb-challenged AM from HC, respectively. The standard deviation of the means is shown by shades for each condition. The location of the motif assigned to the footprint is shown by a black bar at the bottom. We detected a pronounced footprint for ZNF684 in the core promoter of the TNF gene and also in the promoter of IRF9. Motifs for IRF9 were detected in footprints located close to the promoter of the NOD2 and ISG15 genes.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2021. 

Global tuberculosis report

ART and prevention of HIV-associated tuberculosis

Impact of HIV infection on the recurrence of tuberculosis in South India

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi

Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection

Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination

Multiple exposures, reinfection and risk of progression to active tuberculosis

Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs

Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny

Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo

Mycobacterium tuberculosis infection resistance in HIV-infected individuals

IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure

How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners

Tuberculosis incidence rates during 8 years of followup of an antiretroviral treatment cohort in South Africa: comparison with rates in the community

Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function

Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing

Dysregulation of Alveolar Macrophage PPARgamma, NADPH Oxidases, and TGFbeta1 in Otherwise Healthy HIV-Infected Individuals

HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci

Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages

HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy

HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era

Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts

Characteristics and Outcomes of HIV-Infected Patients With Severe Sepsis: Continued Risk in the Post-Highly Active Antiretroviral Therapy Era

Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease

Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position

ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide

Bacterial infection remodels the DNA methylation landscape of human dendritic cells

Salmon provides fast and bias-aware quantification of transcript expression

The chromatin accessibility landscape of primary human cancers

Bioconductor package for differential expression analysis of digital gene expression data

voom: Precision weights unlock linear model analysis tools for RNAseq read counts

stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage

Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities

Identification of transcription factor binding sites using ATAC-seq